As we transition to mid-stage development with our #ophthalmic pipeline and platform, and look to optimize the application of our technologies, Mark Gaffney’s decades of experience in corporate and financing strategy, business development and operations will be invaluable to Oxular’s future growth Oxular Announces Appointment of Mark Gaffney as Chief Executive Officer | Business Wire
Dr. David S. Boyer, MD, an innovator in the realm of retinal and vitreous diseases, specifically Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR), is a key contributor to the US-based Retina-Vitreous Associates Medical Group. His role as a senior partner, overseeing numerous branches across California, has been pivotal in advancing the treatment of retinal …
Dr. Anat Loewenstein, MD, PhD, the respected Chairperson of Ophthalmology at Tel Aviv Medical Center, is globally recognized for her contributions to the early detection of AMD and DME, particularly through innovative home monitoring methods. Her impactful leadership extends to diverse development programs, involving trailblazing trial technologies and unique endpoints, thereby shaping ophthalmology’s future. With …
Anat Loewenstein, MD PhD Chairperson Ophthalmology, Tel Aviv MC Center, IL Read More »
Dr. Allen C. Ho, MD, PhD, esteemed Director of Retina Research at Wills Eye Institute, USA, is globally recognized as a leading retina specialist. Renowned for his innovative work in developing treatments for retinal diseases, including AMD, DR, DME,and gene therapy, Dr. Ho’s contributions significantly impact key pharmaceutical development programs. With over 300 publications in …
Allen C. Ho, MD PhD Director of Retina Resarch at Wills Eye, US Read More »
Dr. Patricia Udaondo, MD, leads the Retina Division at Spain’s Aiken Clinic, bringing her primary research interests in retinal disorders and ophthalmic surgery to the forefront of patient-centric innovation. In addition to her leadership at Aiken Clinic, she has made notable contributions at the University and Polytechnic Hospital La Fe in Valencia. Dr. Udaondo, a …
Patricia Udaondo, MD Head Retina Division, Aiken Clinic, ES Read More »
Dr. Charles C. Wykoff, MD, PhD, is a pioneering force in ophthalmology as the Managing Partner of Retina Consultants of Texas Research Centers and Deputy Chair of Ophthalmology at Houston Methodist Hospital’s Blanton Eye Institute. Known for his innovative leadership and expertise, he has significantly advanced retina care. His commitment to translational research is evident …
Charles C. Wykoff, MD PhD Retina Consultants of Texas, US Read More »
Dr. Jason S. Slakter, MD, PhD, is a globally recognized retinal and posterior segment imaging specialist with over 35 years of experience. He is the Founder and Director of the Digital Angiography Reading Center (DARC) in New York, a leading center for ocular image evaluation for clinical trials. In addition to his work at DARC, …
Jason S. Slakter, MD PhD Imaging (DARC) & Retina Specialist, US Read More »
Chris is Oxular’s Vice President of GMP Drug Manufacturing, with more than 25 years of industry experience, Chris’s experience spans chemistry, manufacturing, and manufacturing controls, pilot-to-full scale production project management in both APIs and finished product, alliance management, injectable product development, formulation development, process development and scale-up, and licensing and partnering. He has also authored or contributed to over 70 patents, publications, and presentations concerning project management, business, and pharmaceutical development. Chris received a BS in Chemistry and an MBA from the University of Albany, USA, and holds a PhD in Synthetic Organic Chemistry from the University of New Hampshire, USA.
Pamela is Oxular’s Senior Director of Regulatory Affairs, with over 30 years of experience working in all aspects of regulatory strategy and submissions. Previously, Pamela managed and coordinated regulatory efforts at Genocea, ProMedDx and Ximedica. She has significant experience in regulatory development, strategy, and filings and brings technical experience in clinical trials design, chemistry, manufacturing, …
Jatinder is Oxular’s Vice President of Quality. He has more than 25 years of experience in the quality assurance function, amassing extensive knowledge in the development and auditing processes of pharmaceuticals, including sterile injectables, oral dosage forms, and liquid suspension preparations, as well as medical devices. Jatinder has worked with several quality pharmaceutical companies, such as Novartis, Shire, and BTG, and has significant experience working with combination medical device and pharmaceutical products. He has overseen product technology transfers, designed and commissioned a sterile API plant, and established numerous quality management systems. He holds a PhD in Synthetic Organic Chemistry from Punjab University, India.
General
+44 (0)1865 636200
inquiries@oxular.com
Magdalen Centre
1 Robert Robinson Avenue
Oxford, OX4 4GA, UK
Limited company registered in
England and Wales
Registration No. 09331313
VAT No. GB 244 5883 81
Copyright Oxular Limited
Media
+1 617 895 9511
monique@thrustsc.com
Monique Allaire
Thrust
Follow us on
Limited company registered in England and Wales (Registration No. 09331313) VAT No. GB 244 5883 81
Copyright Oxular Limited
Website designed by Emerald Grove Studio
Website built by THRH Consulting